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bjectives In view of evidence that mature cells play a role in modulating the stem cell niche and
hereby stem cell potential and proliferation, we hypothesized that a mature bone marrow (BM)
ononuclear cell (MNC) infusion subfraction may have particular potency in promoting hematopoi-
tic or resident stem cell-induced cardiac repair post-infarction.
ackground Treatment of acute myocardial infarction (MI) with BM MNC infusion has shown prom-
se for improving patient outcomes. However, clinical data are conﬂicting, and demonstrate modest
mprovements. BM MNCs consist of different subpopulations including stem cells, progenitors, and
ifferentiated leukocytes.
ethods Stem cells (c-kit) and subsets of mature cells including myeloid lineage, B and T-cells
ere isolated from bone marrow harvested from isogeneic donor rats. Recipient rats had baseline
chocardiography then coronary artery ligation; 1  106 cells (enriched subpopulations or combina-
ions of subpopulations of BM MNC) or saline was injected into ischemic and ischemic border zones.
ell subpopulations were either injected fresh or after overnight culture. After 2 weeks, animals un-
erwent follow-up echocardiography. Cardiac tissue was assayed for cardiomyocyte proliferation and
poptosis.
esults Fractional ventricular diameter shortening was signiﬁcantly improved compared with saline
38  3.2%) when B cells alone were injected fresh (44  3.0%, p  0.035), or after overnight cul-
ure (51  2.9%, p  0.001), or after culture with c-kit cells (44  2.4%, p  0.062). B cells re-
uced apoptosis at 48 h after injection compared with control cells (5.7  1.2% vs. 12.6  2.0%,
 0.005).
onclusions Intramyocardial injection of B cells into early post-ischemic myocardium preserved car-
iac function by cardiomyocyte salvage. Other BM MNC subtypes were either ineffective or sup-
ressed cardioprotection conferred by an enriched B cell population. (J Am Coll Cardiol Intv 2009;
:1005–16) © 2009 by the American College of Cardiology Foundation
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1006eart failure is the leading cause of morbidity and mortality
n the Western world, affecting approximately 5 million
eople in the U.S. (1) and at least 10 million people in
estern Europe (2). Heart transplantation remains the best
vailable treatment option for end-stage heart disease;
owever, donor availability is limited. A potential alterna-
ive approach to the treatment of end stage heart disease is
ell therapy in which bone marrow (BM) stem cells or
ononuclear cells (MNCs) are injected into sites of cardiac
njury. Currently, BM is the most frequent source of cells
sed for cardiac repair in clinical trials and has been shown
o induce modest improvements in cardiac function in
atients with acute myocardial infarction (MI) (3–5) and
hronic ischemia (6–9).
While the mechanisms for improvement remain unclear,
ardiac injection of autologous BM cells in recovery from an
cute MI is an attractive therapeutic option. Potential
echanisms include transplanted cell differentiation into
cardiac myocytes (10,11), fusion
with resident myocytes (12–14),
cytokine-supported recruitment
of circulating progenitor cells
(15,16), and secretion of benefi-
cial paracrine factors (17–20).
Clinical results from this novel
approach have been mixed, and
pre-clinical studies vary in terms
of therapeutic cell types, admin-
istration methods, timing of cell
delivery, and analytical methods.
The optimal BM MNC popula-
tion that induces maximal car-
diac repair remains unclear.
BM contains a complex as-
sortment of progenitor cells, in-
cluding hematopoietic stem cells
HSCs), mesenchymal stem cells, and multipotential adult
rogenitor cells, along with lineage-positive cells such as
onocytes, basophils, eosinophils, and B and T lympho-
ytes. Furthermore, differentiated hematopoietic cells in-
luding T and B lymphocytes have been previously shown to
ontribute to tissue repair and regeneration, and T cells in
articular have been shown to influence the HSC niche
20). The aim of this study was to examine the possibility
hat a unique mature subpopulation of BM cells that, either
lone or in combination with HSC subpopulations, was
rimarily beneficial for repair of infarcted myocardium. The
bjective was to evaluate left ventricular (LV) function in
ats that received intramyocardial injection of various cell
ubpopulations from the BM, administered at the time of
eft anterior descending coronary artery ligation. We hy-
othesized that by removing certain inhibitory or noncon-
ributory mature leukocyte populations, the beneficial effects
bbreviations
nd Acronyms
M  bone marrow
rdU  5-bromo-2=-
eoxyuridine pellets
SC  hematopoietic stem
ell
AD  left anterior
escending artery
V  left
entricle/ventricular
I  myocardial infarction
NC  mononuclear cell
HSC  nonhematopoietic
tem cellf cell therapy in the setting of acute MI could be potenti- cted. Our results demonstrate that a B cell-enriched sub-
raction induces maximal therapeutic effect during recovery
rom acute MI.
ethods
he Saint Joseph’s Research Institute is accredited by the
ssociation for Accreditation and Advancement of Labo-
atory Animal Care. Experimental animal use conformed to
ational Institutes of Health and American Heart Associ-
tion guidelines and was approved by the Institutional
nimal Care and Use Committee of the Saint Joseph’s
esearch Institute, in accordance with the “Guide for the
are and Use of Laboratory Animals” (NIH publication no.
5-23, National Academy Press, Washington, DC, revised
996).
M harvest and cell preparation. Donor male Sprague-
awley rats were anesthetized with ketamine 80 mg/kg with
ylazine 2.0 mg/kg and euthanized via exsanguination. Femurs
nd tibias were harvested and flushed with Dulbecco’s modi-
ed essential medium (Gibco, Grand Island, New York)
upplemented with 2% fetal bovine serum (Gibco), penicillin
00 U/ml (Gibco), and streptomycin (100 g/ml Gibco).
he BM was collected and diluted 1:2 with Dulbecco’s
hosphate-buffered saline then layered onto a Ficoll density
radient (Histopaque-1077, Sigma, St. Louis, Missouri).
he buffy coat was collected and washed with Dulbecco’s
hosphate-buffered saline then subjected to the Miltenyi
iotech (Auburn, California) cell separation procedure. BM
NCs were washed twice in cold buffer (phosphate-
uffered saline, pH 7.2, 0.5% bovine serum albumin and 2
mol/l ethylenediaminetetraacetic acid) then depleted of
on-B cells by a negative selection procedure. BM cells were
ncubated with antibodies specific for mature lineage (Lin)
arkers for: T cells (CD3, clone G4.18, BD Pharmingen,
an Jose, California), helper/inducer T cells (CD4, clone
X-35, BD Pharmingen), suppressor/cytotoxic T cells
CD8, clone X8, Antigenix America, Huntington Station,
ew York), monocytes (CD11b/c, clone OX-42, BD Phar-
ingen), and neutrophils (Granulocyte, clone RP-1, BD
harmingen) and further incubation with phycoerythrin-
abeled magnetic microbeads (Miltenyi Biotech). The un-
abeled BM MNC fraction (Lin negative, Lin) was then
ubjected to positive selection for B cells (CD45RA, clone
X-33, BD Pharmingen) or HSCs (Lin-c-kit, HSC,
-kit, clone H-300, Santa Cruz Biotechnologies, Santa
ruz, California). While Lin-c-kit consist of very prim-
tive cells including stem cells, for simplicity we will refer to
his subset as HSC. Nonhematopoietic stem cells (NHSC)
ere isolated by the addition of CD45RA to the negative
election cocktail followed by positive selection with c-kit
nd considered to be Lin-CD45RA-c-kit-selected cells.
For B cell characterization studies, CD45RA-positive
ells (21) were stained with markers for lymphocytes
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1007CD45R, clone HIS24, BD Pharmingen), thymocytes
CD5, clone OX-19, BD Pharmingen), IgM (clone
ARM-4, Serotec, Raleigh, North Carolina) and IgD
clone MARD3, Research Diagnostics, Concord, Massa-
husetts). Cell subpopulations were analyzed by flow cytom-
try (FACSCalibur, BDIS, San Jose, California). Cell
iability was assessed using Trypan blue exclusion method.
To determine the impact of storage on cell-mediated
ardiac effects as a prelude to possible clinical translation, we
sed cells that were cultured overnight. Cells were incubated
t 37°C with 5% CO2 in Dulbecco’s modified essential
edium with 2% fetal bovine serum and penicillin/
treptomycin either alone or in coculture using the Boyden
hamber system (Falcon, Becton Dickinson Labware, Fran-
lin Lakes, New Jersey). Before injection, cells were washed
n phosphate-buffered saline then resuspended in sterile
ormal saline.
odel of MI and injections of BM cell populations. Male
prague-Dawley rats (250 to 300 g, Charles River
aboratories, Raleigh, North Carolina) were sedated,
ntubated, and anesthetized with inhalant isoflurane
2%). After surgical preparation and drape, using sterile
echnique and equipment, a left lateral thoracotomy was
erformed, and the left anterior descending artery (LAD)
as isolated and ligated using sterile 6-0 prolene. Cardiac
schemia was confirmed by visible blanching in the
nteroapical LV along with ST-segment elevation on
lectrocardiogram (ECG). After ligation of the LAD and
onfirmation of infarction, animals received a total of 106
ells (5  105 of each cell population) in 4 injections of
0 l each intramyocardially in the ischemic LAD
erritory using a 30-G Hamilton syringe. Control animals
eceived saline (4 injections of 20 l each). The chest was
losed using sterile sutures (4-0 vicryl), and the animal
ecovered post-operatively.
ssessment of wall motion by echocardiography. Transtho-
acic echocardiography (ATL HD5000 with a CL 15-7
Hz probe, Phillips Technologies, Bothell, Washington)
as obtained on all animals immediately before opening the
hest for surgery, and repeated on all animals 2 weeks later
22–24) before sacrifice. A subset of animals underwent
oronary artery ligation followed by immediate echocardio-
raphic assessment after chest closure. A 2-dimensional
hort-axis view of the LV was acquired at midpapillary and
pical levels, and M-mode tracings recorded to allow delin-
ation of wall thickness and motion in infarcted and
oninfarcted territories. Regional wall motion was exam-
ned per published criteria (25). The M-mode tracings were
nalyzed by an experienced echocardiographer who was
linded to treatment group assignment. Relative anterior
nd posterior wall thickness, and LV internal dimension was
easured from at least 3 consecutive cardiac cycles, and anverage value obtained. Endocardial and midwall, fractional pV diameter shortening were considered to represent LV
ystolic function.
istological assessment of infarct size, cellular proliferation,
poptosis, and B cell retention. After euthanization, hearts
ere perfusion rinsed with saline then perfusion fixed with
% paraformaldehyde via aortic cannula. Hearts were cut
nto 5 transmural cardiac sections, embedded in paraffin,
hen processed for infarct size, cellular proliferation, or
ellular apoptosis. Sections 6- to 8-m thick were cut on a
otary microtome, adhered to glass slides, and adjacent or
ear-adjacent sections were stained with picric acid fuchsin
o measure infarct size. For infarct measurement, prominent
icrosirius red-stained LV areas were traced from low-
agnification microscopic images (Image Pro Plus, Media
ybernetics, Rockville, Maryland) and expressed as a per-
entage of total LV wall area.
To assess cellular proliferation over a 2-week period, a
ubset of animals was implanted with 5-bromo-2=-
eoxyuridine pellets (BrdU) (5 mg/pellet, 21-day release,
nnovation Research of America, Sarasota, Florida) subcu-
aneously at the time of LAD ligation and B cells (n  10),
cells cultured overnight at 37°C (n  10), and B cells
ocultured with NHSC (n  4) transplantation. Sham-
perated (no ligation, n  5) and ligation plus saline
njection (n  6) animals were included as control animals.
t 2 weeks, hearts were harvested and processed as noted in
he previous text followed by deparaffinization, antigen
etrieval (100°C for 30 min, antigen retrieval solution,
AKO, Carpentaria, California), and blocking with hydro-
en peroxide (3%) and normal goat serum (Vector Labora-
ories, Burlingame, California). Sections were incubated
ith horseradish peroxidase-conjugated rat-specific anti-
ody against BrdU (DAKO) and visualized using 3,3=-
iaminobenzidine (Vector Laboratories). Double immuno-
taining was performed to determine the cellular phenotype
f the proliferating cells. Sections were also stained with
rdU as described in the preceding text along with various
arkers for endothelial cells (von Willebrand factor, Sero-
ec) or for cardiac myocytes (sarcomeric actin, clone 5C5,
bcam, Cambridge, Massachusetts).
In order to measure cellular apoptosis, a subset of animals
nderwent induction of MI followed by injections of saline
n  6) or with B cells (n  6) or B cell cocultured with
HSCs (n  4). These animals were then euthanized at
8 h post-infarction. Sections were prepared as noted in the
receding text then processed according to the manufacturer’s
nstructions by terminal nucleotidyl nick-end labeling,
UNEL, assay (DeadEnd Colorimetric TUNEL System
romega, Madison, Wisconsin).
Retention of injected B cells was assessed at 2 weeks, and
issue sections were processed as described in the preceding
ext. Sections were incubated with CD45RA (clone OX-33,
D Pharmingen) followed by incubation with horseradish
eroxidase-labeled secondary antibody then visualized using
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1008,3=-diaminobenzidine (Vector Labs). All nuclei were coun-
erstained with hematoxylin.
tatistical analysis. Continuous variables are presented as
ean  SEM. The effect of cell treatment on dependent
ariables was assessed either by analysis of variance with
isher least significant difference post hoc analysis or with
tudent t tests, as appropriate. A critical value of p  0.05
as considered to indicate a significant treatment effect or
ifference between groups.
esults
at survival and conﬁrmation of cardiac ischemia after coro-
ary artery ligation. A total of 125 male Sprague-Dawley
ats (8 to 10 weeks old) underwent coronary artery ligation;
5 rats died within 24 h of surgical induction of MI (overall
Figure 1. Purity and Characterization of Selected B Cells From Rat Bone M
Flow cytometric analysis of bone marrow-derived CD45RA-positive B cells reve
other lineage-positive bone marrow cells including cytotoxic T cells (CD8) (B
type control is shown in A. Flow cytometric analysis of bone marrow-derived C
lymphocytes (G). IgM-positive immature B cells (H), IgG-positive mature B cells
derived B cell fraction did not contain CD5-positive marginal cells (J). Isotype
for c-kit is shown in K. Representative ﬂow cytometry data are shown.nimal mortality was 12%). Cardiac ischemia was confirmed
n all rats by visible blanching in the anteroapical LV along
ith ST-segment elevation on ECG (Online Fig. 1).
low cytometric characterization of BM-derived B cells. The
at leukocyte-common antigen (CD45R) found on thymo-
ytes and T and B lymphocytes are heterogenic in both
olecular and antigenic structure and antibody binding. It
as been shown that the OX-33 clone (CD45RA)
ntibody only binds to B cells and thus the CD45RA
ntibody was selected for separation of an enriched B cell
opulation from rat BM. Flow cytometric analysis of
M-derived CD45RA-selected B cells (Fig. 1) illustrates
hat the B cell population was relatively pure as deter-
ined by staining with antibodies towards cytotoxic T
ells (Fig. 1A) (CD8; 5  4%), T cells (Fig. 1B) (CD3;
 0.1%), helper T cells (Fig. 1C) (CD4; 2  0.4%),
hat the injected population of CD45RA selected B cells were relatively free of
ral killer T cells (CD3) (C), helper T cells (CD4) (D), and neutrophils (E). Iso-
A-positive B cells conﬁrmed the majority of the B cells are CD45R-positive
nd a minority of early c-kit positive pro-B cells (L). The bone marrow-
l for CD45R, IgM, IgG, and CD5 antibodies is shown in F, and isotype controlarrow
aled t
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1009nd neutrophils (Fig. 1D) (12  11%). The purity of the
ther cell populations, including T cells, monocytes,
eutrophils, tested was greater than 95% (data not shown).
BM-derived CD45RA B cells were characterized by
ow cytometry and reveal that approximately one-half of
he cells also express the CD45R marker (Fig. 1F) (47 
6%). Many of the CD45RA B cells were immature B
ells (Fig. 1G) (IgM; 21  11%) and mature B cells (Fig.
H) (IgG; 17 11%). A very small proportion of these cells
ere considered to be mature marginal B cells (Fig. 1I)
CD5; 1  0.1). A very small proportion of CD45RA B
ells were also positive for the stem cell marker c-kit (Fig.
G) (1  0.1%).
Using flow cytometric analysis, characterization of HSCs
nd NHSCs revealed that HSCs were positive for c-kit (34
0.17%), positive for CD45RA (36 0.17%), and positive
or panCD45 (33  0.17%). In addition, NHSCs were
ositive for c-kit (48 0.06%), positive for CD45RA (48
.06%), and positive for panCD45 (46  0.04%).
ffect of intramyocardial injections of isolated BM popula-
ions on LV diameters and fractional diametric shortening.
hen saline was injected into the infarcted myocardium,
V function as reflected by LV short-axis fractional ven-
ricular diameter shortening (Fig. 2) was reduced compared
ith the sham condition (38 3.2%, n 15 vs. 53 2.7%,
 9, respectively; p  0.001). Injections of HSCs or
oinjections of HSCs with B cells were not associated with
unctional improvement compared with saline control in-
ections. However, a significant improvement in diametric
hortening occurred after injections of B cells alone (44 
.0%, n  23, p  0.035) and cultured B cells (51  2.9%,
 11, p  0.001) when compared with injections of
aline. Additionally, there was a functional improvement
ith injections of B cells after overnight coculture with
HSCs compared with injections of saline, but this did not
each statistical significance (44  2.4%, n  14, p 
.062). No other BM cell subpopulation was associated with
mproved LV function including treatment with coinjec-
ions of HSCs with T cells (29  4.4%, n  6, p  0.828),
SCs with monocytes (27  6.0%, n  6, p  0.101), and
SCs with neutrophils (25  2.2%, n  6, p  0.571).
ffect of intramyocardial injections of isolated BM popula-
ions on infarct size, cellular proliferation, apoptosis, and
ocalization of B cells. After euthanization, hearts were
erfusion-rinsed with saline, perfusion-fixed, then stained
or collagen to measure infarct size (Online Fig. 2). Injec-
ion of BM-derived B cells did not affect infarct size and was
ot significantly different from saline-treated animals (p 
.356): saline (18.89  3.85%, n  9); B cells (17.89 
.85%, n  23); cultured B cells (15.06  2.16%, n  12);
nd B cells after overnight coculture with NHSCs (14.01 
.74%, n  18). A small amount of collagen deposition was
bserved in the no ligation animals most probably due to the fissue trauma associated with the passage of the needle and
igature through the myocardium (2.54  1.51%, n  12).
In order to explore the mechanism(s) mediating the
rotective effects of B cells on myocardial function, we
etermined cumulative cellular proliferation over the
-week period within infarcted regions of the myocardium.
nimals received subcutaneous BrdU administration con-
omitant with coronary artery ligation and were terminated
weeks later. Immunohistochemical staining of BrdU-
abeled proliferating cells was performed on the cardiac
ection with the greatest infarct, and positively BrdU-
tained cells were counted within the infarct and border
ones. There were no significant differences in cellular
roliferation detected between control animals injected with
aline or those in which coronary artery ligation was not
erformed (4.3  1.2%, n  6 vs. 4.0  1.1%, n  5,
espectively; p  0.840), B cells injected (6.3  1.6%, n 
0, p  0.345), cultured B cell injected (6.8  1.9%, n 
0, p  0.332), and B cells that had been cocultured
vernight with NHSCs (7.5  1.9%, n  4 vs. 4.3  1.2%,
 6, p  0.123) rats (Fig. 3). When the data were
nalyzed by using raw values rather than the mean values,
ignificant increases were detected in cellular proliferation
fter transplantation of cultured B cells (6.8  1.86%, n 
0, p  0.032) and B cells that had been cocultured
vernight with NHSCs (7.5  1.90%, n  4; p  0.002),
ompared with controls injected with saline (4.3  1.17%,
 6). There were no significant differences in cellular
roliferation detected comparing control animals injected
ith saline with no ligation (4.3  1.20% vs. 4.0  1.09%,
 6, respectively; p  0.565), B cell injected
6.3  1.57%, p  0.076) rats. Assessment of the cellular
henotype performed by staining with an endothelial cell
arker and a cardiac myocyte marker did not show colo-
alization with BrdU-labeled proliferating cells (Fig. 4).
We proposed that early myocardial salvage by B cells after
nfarction was another potential mechanism of cardiac
rotection. Animals were terminated 48 h after coronary
rtery ligation, and cell injection procedure and cellular
poptosis were determined by immunohistochemical stain-
ng using the TUNEL assay. Apoptotic cells were counted
n each cardiac section, and the data presented as the mean
enerated from all cardiac sections. Animals treated with B
ells cocultured with NHSCs had significantly fewer apop-
otic cells 48 h after MI (Fig. 5) compared with saline-
reated animals (3.5  0.6%, n  4 vs. 4.2  1.2%, n  6,
espectively; p  0.035). There was no significant difference
etected in cellular apoptosis between rats treated with
aline compared with animals treated with B cells (4.2 
.2%, n 6 vs. 2.8 0.8%, respectively, n 6, p 0.580).
hen we compared the data from the single cardiac section
hat had the highest number of apoptotic cells from the
aline-treated control animals (12.6  2.0%, n  6), we
ound that B cell treatment resulted in significantly less
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Figure 2. Echocardiographic Fractional Diametric Shortening
Two weeks after transplantation of B lineage and stem cell populations into infarcted rat myocardium, the surviving animals underwent follow-up echocardio-
graphic assessment. Representative M-mode echocardiography is shown in A. B is a graph of normal (shaded squares, n  9), immediate post-ligation (shaded
circles, n  9), sham operated (no ligation, open squares, n  15), and ligation plus saline injection (open circles, n  15) animals were included as control
animals. Solid triangles represent animals injected with hematopoietic stem cells (HSC) (n  4); solid diamonds represent animals injected with HSC coinjected
with B cells (n  5); solid circles represent B cell-injected animals (n  24). B cells cultured overnight at 37°C (n  11) are represented by solid squares, and B
cells cocultured with nonhematopoietic stem cells (NHSCs) cultured overnight at 37°C are represented by patterned squares (n  18). Each data point represents
1 animal, and horizontal bars are the mean  SE. Signiﬁcant differences in the mean values are denoted by *p  0.05 using analysis of variance with post-hoc
analysis using Fisher least signiﬁcant difference.
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Figure 3. Cellular Proliferation, Preservation of Cardiac Tissue, and B Cell Localization After B Cell Injection Into Infarcted Myocardium
Animals were implanted with a 5-bromo-2’-deoxyuridine pellet at the time of infarction and cell injection for determination of cumulative cellular proliferation.
After 2 weeks, animals were euthanized and hearts processed for assessment of 5-bromo-2’-deoxyuridine pellet incorporation into the nuclear DNA of proliferat-
ing cells of ligation plus saline-treated animals (A), or B cells cocultured with nonhematopoietic stem cells (B), B cell (C) and cultured B cell (D) injections. Posi-
tive cells were identiﬁed using antibodies directed against a 5-bromo-2’-deoxyuridine pellet. All nuclei were stained with hematoxylin. The percentage of cells
staining positive for 5-bromo-2’-deoxyuridine pellet was determined by comparison with the total number of cells visualized in a minimum of 5 ﬁelds (200
magniﬁcation). Scale bars are 100 m. Sham operated (no ligation, open squares, n  5) and ligation plus saline injection (open circles, n  6) animals were
included as control animals (E). Solid circles represent animals injected with B cells (n  10). B cells cultured overnight at 37°C (n  10) are represented by
solid squares, and B cells cocultured with nonhematopoietic stem cells cultured overnight at 37°C (n  4) are represented by patterned squares. Each data
point represents the percentage of 5-bromo-2’-deoxyuridine-positive cells counted in a single ﬁeld, and the horizontal bar represents the mean  SE. Signiﬁ-
cant differences in mean values between control and experimental groups are denoted by *p  0.05 using the Student t test, 2-tailed.
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1013ells are retained within the myocardial infarcted region 2
eeks after injection (Fig. 6). Staining of sections with
sotype control antibody revealed no positive staining of
equential sections (data not shown).
iscussion
e demonstrated that rats receiving intramyocardial injec-
ions of B cells at the time of ischemic injury induced by
oronary artery ligation consistently showed improved LV
unctional outcome compared with sham-injected control
nimals. This beneficial effect was maintained when B cells
ere cultured overnight alone or in the presence of NHSCs.
o other BM cell subpopulation or unfractionated total BM
ell population tested was associated with cardiac functional
mprovement. We do acknowledge that echocardiography
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Figure 5. Preservation of Cardiac Tissue and B Cell Localization After B Ce
Histological assessment of cellular apoptosis was performed using the TUNEL
(B) or B cell cocultured with nonhematopoietic stem cell (NHSC) (C) injections
evaluation of apoptosis. Apoptotic cells within the peri-infarct domain were qu
nuclei were stained with hematoxylin. The percentage of cells staining positive
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101426–28) failed to reproduce these findings. Instead, the
ransplanted cells adopted a mature hematopoietic pheno-
ype in the myocardial scar (26–28) accompanied by statis-
ically significant improvement in cardiac function (26). Of
articular note, the BM-derived lineage-negative c-kit
ells had differentiated into alternate cell types including B
ells. Functionally, Balsam et al. (27) reported improved
ractional shortening, decreased LV chamber dimensions at
nd-diastole and end-systole though no significant differ-
nces in infarct size and hemodynamic parameters in BM-
erived c-kit cell-treated versus control mice at 6 weeks.
hile we did not detect these same functional results when
M-derived c-kit cells were injected into infarcted rat
earts, we did observe the same pattern of functional
mprovement in ventricular chamber dimensions without
orresponding improvements in hemodynamic measure-
ents and reduction in infarct size when B cells were
njected. Thus, it is interesting to speculate that in the study
y Balsam et al. (27) the small but significant improvements
n cardiac function were due to the influence of the
M-derived c-kit differentiated B cells. These findings
upport the view that a mature hematopoietic cell such as a
cell can augment cardiac function possibly through the
ffect of paracrine factors it releases that influence the
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Figure 6. B Cell Retention After Injection Into Infarcted Rat Myocardial Tis
Immunohistochemical detection of CD45RA-positive cells within the border zo
(A), B cells (B), cultured B cells (C), and B cells cocultured with nonhematopoi
CD45RA and visualized using 3, 3’-diaminobenzidine in which all positive cells
magniﬁcation 400. Scale bars are 50 m.ardiac stem cell niche. iB cells play a diverse role in the pathogenesis of variety of
ifferent diseases including autoimmune disorders and have
ecome a major therapeutic target in these illnesses. In
ddition to well-established contributions of B cells to
ntibody-mediated physiological and pathological pro-
esses, B cells also play important regulatory and potentially
athogenic roles through antibody-independent mecha-
isms including antigen presentation, T cell activation and
olarization, dendritic cell regulation, and cytokine and
hemokine production (29). Novobrantseva et al. (30)
ecently reported that mature B cells play a role in CCl4-
nduced hepatic fibrosis in mice in an antibody-independent
anner. The authors demonstrated that B cell-deficient
ice had decreased collagen deposition and were able to
lear apoptotic cells faster than wild-type mice. In addition,
hey examined whether B cell regulation of fibrosis required
g production. Mice with normal B cell numbers that lack or
ad low serum Ig were found to develop a similar degree of
brosis when compared with wild-type mice indicating that
cells have an impact on liver fibrosis in an antibody-
ndependent manner. In our studies, BM-derived B cells
ad no apparent effect on cardiac fibrosis as there was no
ifference in infarct size between cell-treated and saline
ontrol animals. In other work, adoptive transfer of B cells
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1015ng gene-1) conferred renal protection after ischemia reper-
usion injury (20). B cells have also been shown to be
rotective against atherosclerosis progression, manifested
hen splenectomy severely aggravated atherosclerosis in
poE/ mice were fed a cholesterol-enriched diet (31).
he same authors reported that enhanced atherosclerosis
fter splenectomy could be abrogated by passive transfer of
plenic cells isolated from apoE/ mice and that this
escue was more complete if the cells were obtained from
onors that were older and, therefore, had greater disease.
hey hypothesized that these B cells could be more “edu-
ated” and were able to transfer specific, enhanced immu-
ocompetence that provided protection from disease. Fi-
ally, Wassmann et al. (32) reported that transfer of
pleen-derived B cells significantly improved endothelium-
ependent vasodilation in apoE/ mice. These datasets
upport our thesis that B cells mediate antibody-
ndependent effects, including the preservation of ventricu-
ar function after ischemic injury.
linical signiﬁcance. Phase I clinical trials using cell therapy
or acute MI and chronic ischemia have shown reasonable
mprovement in cardiac function. BM cells used in the clinic
nclude hematopoietic and mesenchymal stem cells, and
ndothelial progenitor cells. Stem and progenitor cells must
e cultured for extended periods to generate sufficient cell
umbers for therapeutic benefit thereby limiting clinical
tility. Additionally, appropriate facilities for long-term
ulture of autologous stem/progenitor cells are not readily
nd widely available. BM-derived B cells are lineage-
ositive and can be isolated from autologous sources in large
umbers; this might eliminate the need for in vitro expan-
ion to accomplish therapeutic benefit. In the future, B cell
ransplantation may prove clinically useful for cardiovascular
iseases.
onclusions
M-derived B cells improve cardiac function after trans-
lantation into infarcted rat myocardium. Mechanisms for
cell-dependent improvements include a reduction in
ardiac apoptosis in conjunction with increased cellular
roliferation. Further, more detailed studies of cellular and
olecular mechanisms, correlations to other species, and
he definition of the optimal B cell subpopulation to
itigate against cardiac ischemic damage are warranted.
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